Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023

SELL
$84.98 - $122.67 $504,951 - $728,905
-5,942 Reduced 59.91%
3,976 $450,000
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $757,239 - $934,077
9,918 New
9,918 $799,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Chimera Capital Management LLC Portfolio

Follow Chimera Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chimera Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chimera Capital Management LLC with notifications on news.